U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07302360) titled 'A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis' on Dec. 11.
Brief Summary: The purpose of this study is to assess the measurable changes in health, function, or quality of life (clinical outcomes) after receiving guselkumab in real-world clinical practice amongst Chinese participants with ulcerative colitis (UC; a long-term disease of the large intestine in which the lining of the colon [part of large intestine] becomes inflamed and develops tiny open ulcers), who have not received biologic therapy (a medicine made from living organisms or their components) previously.
Study Start Date: Jan. 31, 20...